News
Twenty-Two Years of Progress: The Critical Impo...
Sherrie was diagnosed with Stage II RET+ thyroid cancer twenty-two years ago in 2003: two years before the first oncogene-targeting therapies were FDA-approved and 14 years before trials for the...
Twenty-Two Years of Progress: The Critical Impo...
Sherrie was diagnosed with Stage II RET+ thyroid cancer twenty-two years ago in 2003: two years before the first oncogene-targeting therapies were FDA-approved and 14 years before trials for the...
mRNA COVID Vaccines Appear to Boost Cancer Immu...
A major study led by The University of Texas MD Anderson Cancer Center, shared at the 2025 European Society for Medical Oncology Congress, tracked over 1,000 cancer patients treated between...
mRNA COVID Vaccines Appear to Boost Cancer Immu...
A major study led by The University of Texas MD Anderson Cancer Center, shared at the 2025 European Society for Medical Oncology Congress, tracked over 1,000 cancer patients treated between...
RETpositive at LUNGevity’s Fall Science Meeting...
Each year, LUNGevity convenes current research awardees, patient advocates, and its Scientific Advisory Board for a Fall Science Meeting to foster dialogue, build collaborations, and strengthen the research community (1)....
RETpositive at LUNGevity’s Fall Science Meeting...
Each year, LUNGevity convenes current research awardees, patient advocates, and its Scientific Advisory Board for a Fall Science Meeting to foster dialogue, build collaborations, and strengthen the research community (1)....
Federally Funded Cancer Research is Under Threat
Health and Human Services and National Institutes of Health: Pillars of Global Biomedical Innovation For decades, the United States has been the world's biomedical leader - by a mile. That...
Federally Funded Cancer Research is Under Threat
Health and Human Services and National Institutes of Health: Pillars of Global Biomedical Innovation For decades, the United States has been the world's biomedical leader - by a mile. That...
Two New Lung Cancer Nonprofits Meet Critical Un...
Two exciting new lung cancer nonprofits are emerging to address critical gaps in support:Oncogene Cancer Research (OCR): This patient and family-driven organization advocates for and funds research specifically focused on...
Two New Lung Cancer Nonprofits Meet Critical Un...
Two exciting new lung cancer nonprofits are emerging to address critical gaps in support:Oncogene Cancer Research (OCR): This patient and family-driven organization advocates for and funds research specifically focused on...
ADC Drugs Offer Hope for RET+ NSCLC Patients
In case you missed it, one promising report from ASCO 2023 offers hope to patients who may be looking for additional options after RET-TKI's. Telisotuzumab vedotin (teliso-v) is a new...
ADC Drugs Offer Hope for RET+ NSCLC Patients
In case you missed it, one promising report from ASCO 2023 offers hope to patients who may be looking for additional options after RET-TKI's. Telisotuzumab vedotin (teliso-v) is a new...